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Background: Kabuki syndrome (KS) is a rare, multiple congenital anomalies/intellectual disability syndrome caused
by mutations of MLL2 gene, which codifies for a histone methyltrasferase that regulates the embryogenesis and the
tissue development. Left-bronchial isomerism is a rare congenital abnormality that can be defined as the absence
of the normal lateralizing features which distinguish right and left-sides in the lungs. To date, this is the first report
of left-bronchial isomerism in association with KS.
Case presentation: A one-month-old Caucasian male patient underwent our attention for microcephaly,
dysmorphic features (long palpebral fissures, eyebrows with sparse lateral third, everted lower eyelids, blue sclerae,
large dysplastic ears, lower lip pits), persistent fetal fingertip pads, short stature, heart defects (interventricular defect
and aortic coarctation), unilateral cryptorchidism, hypotonia and delay in gross motor skills. These features
suggested a diagnosis of KS and a molecular analysis confirmed a novel frame-shift mutation in the exon 11 of
MLL2 gene. Subsequently, given recurrent respiratory infections with a normal immunological status, he underwent
a chest CT scan that showed a left bronchial isomerism.
Conclusion: We report a patient affected by KS, with a novel MLL2 mutation and an atypical phenotype characterized
by left-side bronchial isomerism. Interestingly, genes involved in the heterotaxia/isomerism such as ROCK2 and
SHROOM3 are known to interact with MLL2 gene. In order to achieve a correct diagnosis and an appropriate therapy,
the presence of pulmonary anatomical variations should be investigated in KS patients with respiratory signs not
associated to immunological deficiency. Finally, our findings support the hypothesis that the mutations leading to a
complete loss of function of MLL2 gene is often associated with complex visceral malformations.
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Kabuki syndrome (KS) is a rare congenital disorder, char-
acterized by typical facial features including: long palpe-
bral fissures, eversion of the lateral third of the lower
eyelids, arched and broad eyebrows with lateral sparse-
ness, short columella and large prominent ears. Other
main clinical features are: mild or moderate intellectual
disability, persistent fetal fingertip pads, minor skeletal
anomalies (digital and vertebral anomalies) and hypodon-
tia. Additional features include short stature, internal
malformations (involving the heart, genitourinary and
gastrointestinal systems) and immunological defects [1].* Correspondence: daniela.melis@unina.it
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distribution, and reproduction in any mediumPoint mutations and large intragenic deletions and du-
plications of the histone methyl transferase MLL2 gene
are the main causes of KS [2-9]. MLL2 encodes a large
protein that belongs to the SET1 family of human SET-
domain protein methyltransferase superfamily. Recently,
de novo partial or complete deletions and point muta-
tions of the gene, lysine demethylase 6A (KDM6A),
mapping at Xp11.23 have been identified as additional
causes of KS confirming the genetic heterogeneity of the
disease [10,11]. KDM6A demethylates di- and trimethyl-
lysine 27 on histone H3, maintaining embryonic stem
cell pluripotency and plasticity during embryonic devel-
opment and X chromosome inactivation [12].
Lateralization disorders are divided into complete (ie,
situs inversus totalis) and incomplete forms (ie, hetero-
taxy). In particular, heterotaxy is a malformation wheretral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
Figure 1 Patient facial appearence at a) 20 days and b) 1 year
and 10 months of age respectively; note the high forehead,
lateral sparseness of the eyebrows, long palpebral fissures,
everted lower eyelids, blue sclerae, large dysplastic ears, lower
lip’s pits (see the arrows).
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normal arrangement across the left-right axis of the body,
often involving a wide range of very complex cardiac le-
sions. Heterotaxy syndromes can be further classified in
two main subgroups, including right-sided isomerism and
left-sided isomerism, often associated with asplenia and
polysplenia, respectively. In isomerism, the absence of the
normal lateralizing features makes right and left-sided or-
gans hard to distinguish. Left bronchial isomerism is char-
acterized by anatomical features of bilateral left lung (two
bilobed lungs, each one with a long main bronchus) [13].
Here we describe a male patient with a novel 11 nucleo-
tides deletion in exon 11 of MLL2 gene, presenting with
distinctive features of KS and atypical ones such as neo-
natal hypoglycemia, and left-side bronchial isomerism.
Case presentation
Clinical report
The patient was born at 37 weeks of gestation by spontan-
eous vaginal delivery. The pregnancy was complicated by
intrauterine growth restriction during the first trimester;
furthermore prenatal ultrasound showed left pyelectasis,
single umbilical artery, aortic coarctation with ventricular
septal defect. His parents were unrelated and there was no
family history of any known inherited condition. His birth
weight was 2.420 Kg (<10th centile), length 47 cm (25th
centile), head circumference 31 cm (<5th centile). The
Apgar scores were 7 at 1’, 8 at 5’. At birth, he was admitted
to intensive care unit for the presence of respiratory
distress and hypoglycemia (44 mg/dl), quickly reverted
after treatment with glucose solution. At 4 days of life he
underwent surgery for aortic arch enlargement and coarc-
tation repair through a left thoracotomy.
Since he was one-month-old, he was referred to Genetic
Pediatric Clinic Unit of the Department of Translational
Medicine, Federico II University. The physical examin-
ation revealed: microcephaly, peculiar facial appearance
(high forehead, lateral sparseness of the eyebrows, long
palpebral fissures, everted lower eyelids, blue sclerae, large
dysplastic ears, lower lip pits), persistent fetal fingertip
pads, bilateral gynecomastia, right cryptorchidism and in-
guinal hernia and hypotonia. His weight-for-length ratio
was significantly below the 5th percentile (Figure 1A, B).
An X-ray showed a D6 “butterfly vertebra”. He exhibited
a delay in gross motor skills. A clinical diagnosis of KS
was proposed. At the age of six months, auxologic pa-
rameters were: weight 4,810 kg (<5°); length 62,8 cm
(<5°); W/L <5° ct; head circumference 37 cm (<5°).
Cryptorchidism was still present.
Transfontanellar ultrasound showed corpus callosum
dysgenesis; ophthalmologic examination identified pale
optic disc in the right eye. Abdominal ultrasound scan
was normal; no asplenia or polysplenia were observed.
Two other episodes of hypoglycemia (blood glucose levels44 and 55 mg/dl, respectively) occurred in the first
months of life, both required intravenous dextrose. Since
he suffered from recurrent pneumonia, an immunologic
evaluation was performed including: levels of total Ig and
IgG subclasses, lymphocyte classes, lymphocyte prolifer-
ation assays and specific antibody responses, showing
normal data. At the age of 1 year, a chest CT scan with
iv injection of iodine contrast agent was performed,
showing left-side bronchial isomerism (long main bron-
chus, two hyparterial bronchi and bilobed lungs), several
consolidative opacities in the upper and lower lobes in the
right lung, widespread peripheral cylindrical bronchiecta-
sies, bronchial dilatation and bronchial wall thickening.
Moreover, overinflations in the apical segment of the
upper lobes, hyperdense areas and septal lines in posterior
basal segments and diffuse lung architectural distortion,
were observed. In addition, Azygos lobe was detected
(Figure 2).
Cytogenetic analysis and molecular MLL2 gene study
Informed consent was obtained prior to performing any
cytogenetics and molecular assay. Peripheral blood was
collected from the affected child and his parents. High
resolution karyotype revealed no abnormalities. Molecu-
lar genetic testing for suspected KS was performed by
complete DNA sequence analysis of the entire coding
region and flanking introns of the MLL2 gene, as re-
ported [5]. We detected a de novo deletion in exon 11
(c.3161_3171delCGTTGAGTCCC, p. Pro1054HisfsX10).
The predicted protein lacks the most important functional
domains of MLL2, the plant homeodomains (PHD4-6) and
the SET domains that cooperate with the methyltransfer-
ase activity of MLL2 [14]. Thus, although not experimen-
tally investigated in this report, the detected mutation
would be predicted to affect the physiological function of
MLL2 altering the epigenetic and transcriptional regula-
tory properties of the protein.
Figure 2 Computed tomography angiography shows long main
bronchus, two hyparterial bronchi and bilobed lungs
(consistent with left bronchial isomerism), several consolidative
opacities, widespread peripheral cylindrical bronchiectasies,
bronchial dilatation and bronchial wall thickening.
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We describe a patient with KS confirmed by molecular
study, suffering from recurrent respiratory infections due
to left lung anomalies.
The patient carries a 11 bases deletion in the exon 11
of the MLL2 gene, which consists of 54 exons. This dele-
tion determines a frameshift and a stop codon 10 nucle-
otides downstream from this site. The mutation product
is a truncated protein with highly probable loss of func-
tion. However we cannot rule out the possibility that this
mutation result in the degradation of partial or total tran-
scripts due to nonsense-mediated mRNA decay (NMD),
thus contributing to MLL2 protein haploinsufficiency.
This specific deletion has not been previously described,
but its effect can be compared with other frameshift and
with non-sense mutations. The patient described carrying
a truncating mutation ofMLL2 presented a complex heart
defect (interventricular septal disorder and aortic coarcta-
tion), as previously reported in the literature [3].
KS main features are intellectual disability, post-natal
growth delay and peculiar facial appearance. The patient
herein described showed microcephaly, dysmorphic fea-
tures (long palpebral fissures, eyebrows with sparse lateral
third, everted lower eyelids, blue sclerae, large dysplastic
ears, lower lip pits), persistent fetal fingertip pads, short
stature, heart defects (interventricular defect and aortic
coarctation) and genitourinary malformation, leading to
a score of 6 according to Makrythanasis et al. [9]. In
addition, neonatal hypoglycemia, not usually detected in
this syndrome, was observed in the patient.
Although respiratory infections are frequent in KS
[15], and possibly due to immune system dysfunction,
immunological studies showed normal data in our patient.
The recurrent and severe bronchitis caused multiplehospitalizations, leading to a worsening of the patient’s life
quality. The chest CT scan performed with iv injection of
iodine contrast agent showed left bronchial isomerism and
several bronchiectasies. Bronchial isomerism is a rare con-
genital abnormality defined as the absence of the normal
lateralizing features which distinguish right and left-sided
in the lungs. The morphology of the bronchial tree is
defined on the basis of: the length of the main bronchus,
the course of pulmonary artery on the bronchus and the
number of lobes in the lung [16]. Thus, the left bronchial
isomerism is characterized by a long main bronchus, two
hyparterial bronchi, two bi-lobed lungs. The atrial arrange-
ment frequently follows that of the bronchial tree [13].
Two patients with KS were diagnosed with an anomalous
course of the left pulmonary artery whereas a morpho-
logical alteration of the bronchial disposition was not in-
vestigated [17,18]. Left isomerism may be associated with
malrotation of abdominal viscera, polysplenia and congeni-
tal heart disease [16]. In our patient an echocardiogram
confirmed normal atrial arrangement and an abdominal
ultrasound scan showed normal data with no spleen anom-
alies. Several patients with bronchial isomerism present
with severe respiratory injuries, such as: recurrent episodes
of coughing, wheezing, asthma and bronchiectasies. In par-
ticular three patients diagnosed with severe asthma, classi-
fied as resistant to high-dose corticosteroid therapy, were
found to have left bronchial isomerism [13,16,19]. With
the detection of left-bronchial isomerism in our patient,
in order to prevent his recurrent pulmonary infections,
aggressive antibiotic combination together with a regu-
lar chest physiotherapy was started, improving his re-
spiratory performances.
Although the genetic basis of heterotaxy remains largely
unknown, recently several genes have been recognized
in the pathogenesis of this malformation. In particular,
SHROOM3 gene has been associated with heterotaxy syn-
drome; it encodes a cytoskeleton protein responsible for
cellular shape during morphogenesis and it has been pro-
posed as a good candidate for the control of left-right (LR)
patterning. One of SHROOM3 downstream effectors is
Rho Kinase 2 (ROCK2) involved in the proper specification
of LR asymmetry during embryonic development [20].
ROCK2 pathway mediates several cellular functions such
as cell shape modification, migration and proliferation,
through the phosphorylation of different actin dependent
targets [21,22]. Interestingly MLL2 has been shown to
interact with both SHROOM3 and ROCK2 proteins. On
the basis of these data we suggest that patients with MLL2
deficiency and recurrent respiratory infections should be
investigated for defects of lateralization.
Conclusions
We suggest to investigate the presence of bronchial tree
anatomical variations in KS patients with recurrent
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ters. Because of respiratory infections-related bronchial
isomerism are a relevant cause of bronchiectasies, it is im-
portant to perform a precocious diagnosis and to consider
an appropriate treatment. A multidisciplinary approach
could consist of: aggressive medical treatments, flu vaccine
and respiratory physiotherapy, whereas surgery should be
considered in selected patients with extremely severe
bronchiectasies.
In the attempt to state the frequency of lateralization
defects in KS and in order to investigate if bronchopul-
monary congenital malformations are more frequently
associated to KS in presence of non-sense mutations of
MLL2 gene, a study of broncho-pulmonary anatomy
should be performed.
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